Skip to content

Canceled by the investigator. To observe the rehabilitation effect of ultrasound-guided focused shock wave therapy in patients with hip impingement syndrome during conservative period

Intelligent identification of the acetabular glenoid labrum and observation of the efficacy of using shock waves under ultrasound guidance in the treatment of patients with early femoroacetabular impingement syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065761
Enrollment
Unknown
Registered
2022-11-14
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular Impingement (FI) Syndrome

Interventions

Experimental group:Shock wave combined with conventional rehabilitation therapy
Control group:Conventional rehabilitation

Sponsors

Tianjin University of Sport
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the clinical diagnostic criteria for hip impingement syndrome; 2. Aged between 18 and 60 years; 3. Patients with mild to moderate pain and limited mobility; 4. Patients who have not achieved surgical signs and are inclined to conservative treatment; 5. Those who have taken the Hamilton Anxiety Scale test and obtained the consent of the researchers; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Other hip joint diseases, such as hip arthritis, femoral head necrosis, severe hip effusion, perihip microfracture, etc. 2. Those who have not had hip surgery or any invasive surgery, as well as physical therapy or lower limb strengthening. 3. Patients with severe cardiovascular and cerebrovascular diseases, nervous system diseases and knee and ankle joint diseases. 4. Pregnant and lactating patients. 5. Those who fail to attend treatment and training on time and regularly in the future. 6. Patients who have had hip closure tests or other injections within the last 6 weeks.

Design outcomes

Primary

MeasureTime frame
Harris Score;Visual Analogue Scale;International Hip Outcome Tool;

Secondary

MeasureTime frame
Quality of life;Muscle strength;

Countries

China

Contacts

Public ContactYang Yuping

Tianjin Institute of Physical Education/ Peking University Third Hospital

yyyyppvip@sina.com+86 13611000819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026